MOVE-1 Study: Smartwatch Monitoring Feasibility in Head and Neck Cancer Survivors

Fifty percent of screened head and neck cancer survivors agreed to participate in a smartwatch monitoring study. The dataset, authored by Karl Vietinghoff and shared via figshare in 2026, contains results from the MOVE-1 cross-sectional feasibility study, including recruitment rates, adherence metrics, and usability scores. Thirty-five participants wore smartwatches for a median of 111 hours, with 60% using the display functions often.

Use Cases

• Assess recruitment feasibility for digital health studies based on reported 50% recruitment rate and reasons for refusal.
• Evaluate wearable device adherence in cancer survivors based on median wearing time of 111 hours (67% of target).
• Analyze perceived usability of consumer smartwatches for patient monitoring based on System Usability Scale (SUS) scores.
• Benchmark physical activity levels in a clinical cohort based on the reported median daily step count of 7,298 steps.

Strengths

• Includes specific feasibility metrics: 50% recruitment rate, 67% median adherence to wearing time.
• Reports concrete usability outcomes: mean SUS score of 74 (percentile rank 69, grade B).
• Provides demographic and clinical context for a specific patient population: 35 head and neck cancer survivors with a median age of 63.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• The dataset is small in scale (324.6 KB), indicating limited scope.

Provenance

Source

Karl Vietinghoff via figshare.

Collection Method

Cross-sectional study (MOVE-1) where participants wore a smartwatch continuously for seven days.

Freshness

Last updated 2026-06-03 04:49:57; freshness should be verified.